公开(公告)号：EP3978073A1

公开(公告)日：2022-04-06

申请号：EP20815167.0

申请日：2020-05-29

申请人： Ube Industries, Ltd.

发明人： KOMORI, Ken-ichi ,  NISHIYAMA, Hayato ,  KINOSHITA, Naoya ,  WADA, Yukinori ,  MORISHITA, Kousuke ,  NINOMIYA, Akishi ,  SHIRAISHI, Yuusuke ,  ONUMA, Kazuhiro ,  OGI, Sayaka ,  KAWADA, Hiroyoshi ,  KIMURA, Tomio

IPC分类号： A61P13/12 ,  A61P43/00 ,  C07D413/10 ,  C07D498/04 ,  A61K31/553

摘要： The present invention provides a compound having Keap1 inhibitory effects and a pharmaceutical composition containing the same. Specifically, the present invention provides a compound represented by the following general formula (I):

[wherein the symbols have the same meanings as those described in the description] or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing the same.